fesoterodine fumarate extended-release tablets

fesoterodine fumarate extended-release tablets
SPL v5
SPL
SPL Set ID 26e8cc63-1e1d-4a77-8f53-4c38bcf0d443
Route
oral
Published
Effective Date 2022-10-10
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
fesoterodine (4 mg)
Inactive Ingredients
starch, corn hypromelloses lactose monohydrate lecithin, soybean magnesium stearate cellulose, microcrystalline povidone talc titanium dioxide xanthan gum ferric oxide yellow polyvinyl alcohol, unspecified

Identifiers & Packaging

Pill Appearance
Imprint: 480 Shape: oval Color: yellow Color: white Size: 13 mm Score: 1
Marketing Status
anda active Since 2017-12-07

Description

NDC 70771-1168-9 in bottle of 90 tablets Fesoterodine Fumarate Extended-release Tablets, 4 mg Rx only 90 tablets NDC 70771-1169-9 in bottle of 90 tablets Fesoterodine Fumarate Extended-release Tablets, 8 mg Rx only 90 tablets


Medication Information

Description

NDC 70771-1168-9 in bottle of 90 tablets Fesoterodine Fumarate Extended-release Tablets, 4 mg Rx only 90 tablets NDC 70771-1169-9 in bottle of 90 tablets Fesoterodine Fumarate Extended-release Tablets, 8 mg Rx only 90 tablets

Package Label.principal Display Panel

NDC 70771-1168-9 in bottle of 90 tablets

Fesoterodine Fumarate Extended-release Tablets, 4 mg

Rx only

90 tablets

NDC 70771-1169-9 in bottle of 90 tablets

Fesoterodine Fumarate Extended-release Tablets, 8 mg

Rx only

90 tablets


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1168-9 in bottle of 90 tablets

Fesoterodine Fumarate Extended-release Tablets, 4 mg

Rx only

90 tablets

NDC 70771-1169-9 in bottle of 90 tablets

Fesoterodine Fumarate Extended-release Tablets, 8 mg

Rx only

90 tablets


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)